65 related articles for article (PubMed ID: 1472279)
21. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
22. Conformational transitions in CD4 due to complexation with HIV envelope glycoprotein gp120.
Denisova G; Raviv D; Mondor I; Sattentau QJ; Gershoni JM
J Immunol; 1997 Feb; 158(3):1157-64. PubMed ID: 9013955
[TBL] [Abstract][Full Text] [Related]
23. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
24. Discovery of small molecular inhibitors targeting HIV-1 gp120-CD4 interaction drived from BMS-378806.
Liu T; Huang B; Zhan P; De Clercq E; Liu X
Eur J Med Chem; 2014 Oct; 86():481-90. PubMed ID: 25203778
[TBL] [Abstract][Full Text] [Related]
25. Probing of CD4 binding pocket of HIV-1 gp120 glycoprotein using unnatural phenylalanine analogues.
Yu X; Talukder P; Bhattacharya C; Fahmi NE; Lines JA; Dedkova LM; LaBaer J; Hecht SM; Chen S
Bioorg Med Chem Lett; 2014 Dec; 24(24):5699-5703. PubMed ID: 25453804
[TBL] [Abstract][Full Text] [Related]
26. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
Schols D; Pauwels R; Desmyter J; De Clercq E
Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563
[TBL] [Abstract][Full Text] [Related]
27. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
Lederman S; Gulick R; Chess L
J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782
[TBL] [Abstract][Full Text] [Related]
28. [The antiviral action of recombinant forms of the human T-lymphocyte CD4 receptor].
Zverev VV; Maliushova VV; Sidorov AV; Pugach AV; Shukhmina NR; Pille ER; Mel'nikova NL; Andzhaparidze OG
Vopr Virusol; 1994; 39(2):56-9. PubMed ID: 7517083
[TBL] [Abstract][Full Text] [Related]
29. [Interaction of human apolipoprotein AI and HIV-1 envelope proteins with the native and recombinant CD4 receptors].
Panin LE; Kostina NE
Vopr Virusol; 2003; 48(1):24-6. PubMed ID: 12608057
[TBL] [Abstract][Full Text] [Related]
30. Polyionic compounds selectively alter availability of CD4 receptors for HIV coat protein rgp120.
Weaver JL; Gergely P; Pine PS; Patzer E; Aszalos A
AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1125-30. PubMed ID: 1979910
[TBL] [Abstract][Full Text] [Related]
31. Construction of a recombinant bacterial human CD4 expression system producing a bioactive CD4 molecule.
McCallus DE; Ugen KE; Sato AI; Williams WV; Weiner DB
Viral Immunol; 1992; 5(2):163-72. PubMed ID: 1319711
[TBL] [Abstract][Full Text] [Related]
32. Simple assay to screen for inhibitors of interaction between the human immunodeficiency virus envelope glycoprotein and its cellular receptor, CD4.
Chams V; Idziorek T; Maddon PJ; Klatzmann D
Antimicrob Agents Chemother; 1992 Feb; 36(2):267-72. PubMed ID: 1605591
[TBL] [Abstract][Full Text] [Related]
33. Heparin mediates binding of S-protein/vitronectin to the envelope glycoprotein of the human immunodeficiency virus and CD4.
Su HR; Boackle RJ
Int Arch Allergy Immunol; 1994 Nov; 105(3):238-44. PubMed ID: 7522689
[TBL] [Abstract][Full Text] [Related]
34. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.
Schols D; Baba M; Pauwels R; Desmyter J; De Clercq E
Proc Natl Acad Sci U S A; 1989 May; 86(9):3322-6. PubMed ID: 2566170
[TBL] [Abstract][Full Text] [Related]
35. Development and characterization of a whole-cell radioligand binding assay for [125I]gp120 of HIV-1.
To LP; Balasubramanian V; Charlton ME; Francis TA; Doyle C; Sweetnam PM
J Immunoassay; 1992; 13(1):61-83. PubMed ID: 1569213
[TBL] [Abstract][Full Text] [Related]
36. [Structural and functional analysis of the human immunodeficiency glycoprotein gp120 with homologous synthetic peptides].
Ketlinskiĭ SA; Kalinina NM; Prusakov AN; Kaurov OA
Vestn Ross Akad Med Nauk; 1996; (8):9-12. PubMed ID: 8963198
[TBL] [Abstract][Full Text] [Related]
37. The effect of cellular receptor diffusion on receptor-mediated viral binding using Brownian adhesive dynamics (BRAD) simulations.
English TJ; Hammer DA
Biophys J; 2005 Mar; 88(3):1666-75. PubMed ID: 15556985
[TBL] [Abstract][Full Text] [Related]
38. Sulphated polysaccharides exert anti-HIV activity at differing sites.
Harrop HA; Rider CC; Coombe DR
Biochem Soc Trans; 1992 May; 20(2):163S. PubMed ID: 1397551
[No Abstract] [Full Text] [Related]
39. The SU glycoprotein 120 from HIV-1 penetrates into lipid monolayers mimicking plasma membranes.
Van Mau N; Missé D; Le Grimellec C; Divita G; Heitz F; Veas F
J Membr Biol; 2000 Oct; 177(3):251-7. PubMed ID: 11014863
[TBL] [Abstract][Full Text] [Related]
40. Mechanical matching between a ligand and receptor.
Peñaherrera A
Faraday Discuss; 2015; 184():71-84. PubMed ID: 26399429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
